0001144204-19-035057.txt : 20190718 0001144204-19-035057.hdr.sgml : 20190718 20190718162554 ACCESSION NUMBER: 0001144204-19-035057 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180831 FILED AS OF DATE: 20190718 DATE AS OF CHANGE: 20190718 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hayward James A CENTRAL INDEX KEY: 0001357784 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36745 FILM NUMBER: 19961571 MAIL ADDRESS: STREET 1: C/O 25 HEALTH SCIENCES DRIVE STREET 2: SUITE 113 CITY: NEW YORK STATE: NY ZIP: 11790 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED DNA SCIENCES INC CENTRAL INDEX KEY: 0000744452 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380] IRS NUMBER: 592262718 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 50 HEALTH SCIENCES DRIVE CITY: STONY BROOK STATE: NY ZIP: 11790 BUSINESS PHONE: 631-240-8800 MAIL ADDRESS: STREET 1: 50 HEALTH SCIENCES DRIVE CITY: STONY BROOK STATE: NY ZIP: 11790 FORMER COMPANY: FORMER CONFORMED NAME: PROHEALTH MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 20010504 FORMER COMPANY: FORMER CONFORMED NAME: DCC ACQUISITION CORP DATE OF NAME CHANGE: 19990211 FORMER COMPANY: FORMER CONFORMED NAME: DATALINK CAPITAL CORP/TX/ DATE OF NAME CHANGE: 19980306 4/A 1 tv525331_form4a.xml FORM 4/A X0306 4/A 2018-08-31 2018-10-09 0 0000744452 APPLIED DNA SCIENCES INC APDN 0001357784 Hayward James A 50 HEALTH SCIENCES DRIVE STONY BROOK NY 11790 1 1 1 0 Chief Executive Officer Secured Convertible Note 0.54 2018-08-31 4 C 0 1000000 D 2018-08-31 2021-11-28 Common Stock 1935613 1000000 D Secured Convertible Note 0.54 2018-11-29 4 C 0 500000 D 2018-11-29 2021-11-28 Common Stock 953324 500000 D The Secured convertible note was issued in an exempt transaction pursuant to a securities purchase agreement dated August 31, 2018 at a purchase price of 100% of its principal balance. On July 16, 2019 an amendment to the Secured convertible note was entered into, to, among other things, (i) amend the conversion price to $0.54 from $2.50 and (ii) amend the maturity date of the August 2018 Notes to November 28, 2021. The Secured convertible note was issued in an exempt transaction pursuant to a securities purchase agreement dated November 29, 2018 at a purchase price of 100% of its principal balance. On July 16, 2019 an amendment to the Secured convertible note was entered into, to among other things, amend the conversion price to $0.54 from $2.50. /s/ Beth Jantzen Attorney-in-Fact 2019-07-18